X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BRITISH JOURNAL OF OPHTHALMOLOGY

期刊標題檢索 BRIT J OPHTHALM 最新評論: Review speed: 1.0 | Submission hit rate: 5.0 Sharing experience: Su... (2024-07-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BRITISH JOURNAL OF OPHTHALMOLOGY]您好,您是該頁面的第 41008 位訪客。

期刊簡介
期刊名稱BRITISH JOURNAL OF OPHTHALMOLOGY BRITISH JOURNAL OF OPHTHALMOLOGY
LetPub Score
6.7
50 ratings
Rate

Reputation
7.6

Influence
5.5

Speed
9.4

期刊簡稱BRIT J OPHTHALMOL
ISSN0007-1161
E-ISSN1468-2079
h-index137
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.301.8621.987
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Sensory Systems
Q12 / 42
Category: Neuroscience
Subcategory: Ophthalmology
Q16 / 137
Category: Neuroscience
Subcategory: Cellular and Molecular Neuroscience
Q114 / 97

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The British Journal of Ophthalmology (BJO) is an international peer-reviewed journal for ophthalmologists and visual science specialists. BJO publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context.
官方網站http://bjo.bmj.com/
在線稿件提交https://mc.manuscriptcentral.com/bjo
開放訪問No
出版商BMJ Publishing Group
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1917
每年文章數151每年文章數趨勢
黃金OA百分比23.68%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ113/95
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0007-1161%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-6 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【BRITISH JOURNAL OF OPHTHALMOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PROGRESS IN RETINAL AND EYE RESEARCHH-index: 131

    CiteScore: 34.10
    OPHTHALMOLOGYH-index: 217

    CiteScore: 22.30
    Ocular SurfaceH-index: 53

    CiteScore: 11.60
    SURVEY OF OPHTHALMOLOGYH-index: 120

    CiteScore: 10.30
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEH-index: 196

    CiteScore: 6.90
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGYH-index: 67

    CiteScore: 7.60
    AMERICAN JOURNAL OF OPHTHALMOLOGYH-index: 171

    CiteScore: 9.20
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIEH-index: 44

    CiteScore: 3.20
    ACTA OPHTHALMOLOGICAH-index: 77

    CiteScore: 7.60
    CURRENT OPINION IN OPHTHALMOLOGYH-index: 79

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE67688
    OPHTHALMOLOGY43596
    EXPERIMENTAL EYE RESEARCH43411
    EYE40962
    CURRENT EYE RESEARCH38542
    CORNEA37640
    ACTA OPHTHALMOLOGICA37071
    AMERICAN JOURNAL OF OPHTHALMOLOGY35742
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY33294
    JOURNAL OF VISION30422
  •  

    BRITISH JOURNAL OF OPHTHALMOLOGY BRITISH JOURNAL OF OPHTHALMOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [BRITISH JOURNAL OF OPHTHALMOLOGY] 的評論撰寫評論
作者: 墟散冷松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-29 23:04:08 評論於
Review speed: 1.0 | Submission hit rate: 5.0 
Sharing experience: Submitted on 18th July 2024, it has been 12 days and it is still awaiting SE assignment. Is the editor on leave or something? This is the first time it has been so slow, as in the past two submissions were rejected within 3 working days.
(0) 讚! | 墟散冷松

作者: 神古春岚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-17 08:25:28 評論於
It has been 7 days and I am still awaiting SE Assignment
(0) 讚! | 神古春岚

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:13:08 評論於
RUNNING TITLE is usually printed in the header of a published article, as it is more concise
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:17:59 評論於
Not all journals require this item to be completed
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 21:48:15 評論於
Is a running title necessary?
(0) 讚! | 修然小公主

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 11:45:02 評論於
What is the difference between RUNNINGTITLE and TITLE?
(0) 讚! | 八坂篷蔚

作者: 天霜丹山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-21 13:19:48 評論於
Heavy research focus: Clinical experience sharing: Is it normal that there is no text in the proof PDF generated by the submission?
(0) 讚! | 天霜丹山

作者: 荌荌小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-10 22:25:45 評論於
May I ask which aspect of data is being requested to supplement?
(0) 讚! | 荌荌小娘子

作者: 西德德昆西


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-21 13:19:02 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Experience sharing: Submitted three articles, one of which required additional data for in vitro research but was ultimately rejected automatically as the data was not provided. The other two articles, based on animal experiments, were both accepted. Overall, the journal feels very rigorous, but still friendly towards Chinese researchers. All submissions will at least be reviewed, and the comments from reviewers are usually insightful. The first review process typically takes 1-1.5 months, and the revision period is usually two months. Requests for extensions are generally granted with an additional month's time. The publication fee is $400, relatively cheap
(0) 讚! | 西德德昆西

作者: 明冠凝然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-20 11:13:20 評論於
This magazine discriminates against the achievements of Chinese people
(0) 讚! | 明冠凝然

作者: 小碧凡吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-18 16:25:38 評論於
It has been more than ten days since the submission, and the status is still the same. The publication date is 04/11/2018. The research direction is about orbital trauma, with an acceptance rate of about 50%. The review time is about one month. The submission number is SCI2016381, and it has been more than a week since the submission, but the status has been Awaiting SE Assignment. The editor is Judiana Floriejen. Is she on a spring outing?
(0) 讚! | 小碧凡吖

作者: 极乐宏邈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-22 14:58:14 評論於
Are their family's open is sci?
(0) 讚! | 极乐宏邈

作者: Arno Chapman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-11 21:54:05 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 50.0
Experience Sharing: It's been over a week since I submitted my manuscript, and the status has been "Awaiting SE Assignment" all this time. The editor is Judiana Floriejen. I wonder if she has gone on a spring outing
(0) 讚! | Arno Chapman

作者: Matt


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-14 17:47:20 評論於
This journal publishes ophthalmology-related clinical observations, clinically relevant laboratory studies, large-scale reviews, and focused works with global significance. The journal also publishes innovations in surgical, diagnostic and therapeutic topics. It has a fast review period (5 weeks), but a high rejection rate (43%).

(0) 讚! | Matt

作者: 碧桃逸致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-12-14 14:41:17 評論於
Publish clinical investigations in opthalmology, clinical observations, clinically relevant laboratory investigations, large reviews, and regionally significant events with global implications. The journal also publishes innovations in surgery, diagnostics, and treatment that have received regional attention in the "Innovations" and "Global Issues" sections. Submission rate: 23% (original research articles) ● Instant rejection rate: 43%, decision within 1-3 days ● Publication speed: Submission to preliminary decision: average 5 weeks Acceptance to publication: average 16 days (online) average 3 months (print
(0) 讚! | 碧桃逸致

作者: 小野寺慕玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-11-10 13:00:34 評論於
Two weeks later, the manuscript was rejected and submitted to Open
(0) 讚! | 小野寺慕玉

作者: CarterLee


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2016-08-15 16:11:27 評論於
influence factor finally passed 3!It is not difficult to select, and our school can have several articles every year.Chinese ophthalmology is very powerful in the world.Now I have submitted another one. I listened to the advice of my sister and sister, and wrote all the big and small statements. I have already assigned it to the reviewer and prayed.
(0) 讚! | CarterLee

作者: 北海锦文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-12-14 15:10:44 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: The official website states a 50% acceptance rate, but personally I don't feel it is that difficult. Each issue usually includes one or two articles from Chinese authors, making it suitable for Chinese people to submit. The average time for the first review is 5 weeks, from submission to publication is 15 weeks on average, and online publication occurs on average 18 days after acceptance
(0) 讚! | 北海锦文

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-30 11:15:21 評論於
Review Speed: 3.0 | Acceptance Rate: 50.0
Experience Sharing: British publications are very rigorous and not easily fooled
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-30 08:42:10 評論於
So stable, add a little more strength, can't we just break through 3 points? It's really difficult
(0) 讚! | 凌霄高洁

作者: 孤云平彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-21 18:29:04 評論於
Please translate the following passage into English and Japanese, and title them ":" and "
(0) 讚! | 孤云平彤

作者: 孤云平彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-03-09 22:55:18 評論於
Do you charge a layout fee?
(0) 讚! | 孤云平彤

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 20:50:16 評論於
Can we score 3 points next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 南川微澜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-09-12 19:04:54 評論於
2010年2.934 2009年 2.917
(0) 讚! | 南川微澜

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [BRITISH JOURNAL OF OPHTHALMOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*